(Q53546723)

15 May 2018

title

Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features. (English)

1 reference

15 May 2018

author

Antongiulio Faggiano

1

1 reference

15 May 2018

Clarisse Dromain

7

1 reference

15 May 2018

Annamaria Colao

8

object named as

Annamaria Colao

1 reference

15 May 2018

author name string

Jean-Cristophe Sabourin

2

1 reference

15 May 2018

Michel Ducreux

3

1 reference

15 May 2018

Jean Lumbroso

4

1 reference

15 May 2018

Pierre Duvillard

5

1 reference

15 May 2018

Sophie Leboulleux

6

1 reference

15 May 2018

Martin Schlumberger

9

1 reference

15 May 2018

Eric Baudin

10

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 July 2007

1 reference

15 May 2018

published in

Cancer

1 reference

15 May 2018

volume

110

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

265-274

1 reference

15 May 2018

Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

The diagnosis and medical management of advanced neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Pulmonary large-cell neuroendocrine carcinoma (LCNEC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Molecular Markers Help Characterize Neuroendocrine Lung Tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Genetic changes in the spectrum of neuroendocrine lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Somatostatin receptor scintigraphy in patients with carcinoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

The value of octreotide scintigraphy in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Small-cell carcinoma of the rectum: report of two cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Pulmonary atypical carcinoid: Predictors of survival in 106 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Extrapulmonary small cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22791

7 January 2021

Identifiers

DOI

10.1002/CNCR.22791

1 reference

15 May 2018

1 reference

15 May 2018